Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (361-370 of 432) with videos related to

Pageof 44
Sort By:
Frontiers in Neuroscience|November 16, 2020
Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance SpectroscopySamaira Younis, Anders Hougaard, Casper E Christensen, et al.
JAMA Network Open|August 6, 2021
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical TrialLanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, Roberto De Icco, et al.
Frontiers in Medicine|November 7, 2022
Clinical characteristics of combined rosacea and migraineNita K F Wienholtz, Casper E Christensen, Ditte G Zhang, et al.
The Journal of Headache and Pain|May 30, 2019
Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison studyCasper Emil Christensen, Samaira Younis, Ulrich Lindberg, et al.
The Journal of Headache and Pain|May 8, 2019
Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison studyCasper Emil Christensen, Samaira Younis, Ulrich Lindberg, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache|February 11, 2021
Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trialNita Katarina Frifelt Wienholtz, Casper Emil Christensen, Ditte Georgina Zhang, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a <i>post-hoc</i> analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|June 11, 2024
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumabHaidar M Al-Khazali, Håkan Ashina, Rune Häckert Christensen, et al.
Pageof 44

Showing results (361-370 of 432) with videos related to

Sort By:
Pageof 44
Frontiers in Neuroscience|November 16, 2020
Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance SpectroscopySamaira Younis, Anders Hougaard, Casper E Christensen, et al.
JAMA Network Open|August 6, 2021
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical TrialLanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, Roberto De Icco, et al.
Frontiers in Medicine|November 7, 2022
Clinical characteristics of combined rosacea and migraineNita K F Wienholtz, Casper E Christensen, Ditte G Zhang, et al.
The Journal of Headache and Pain|May 30, 2019
Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison studyCasper Emil Christensen, Samaira Younis, Ulrich Lindberg, et al.
The Journal of Headache and Pain|May 8, 2019
Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison studyCasper Emil Christensen, Samaira Younis, Ulrich Lindberg, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache|February 11, 2021
Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trialNita Katarina Frifelt Wienholtz, Casper Emil Christensen, Ditte Georgina Zhang, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a <i>post-hoc</i> analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|June 11, 2024
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumabHaidar M Al-Khazali, Håkan Ashina, Rune Häckert Christensen, et al.
Pageof 44